[1] MacEwen CJ, Young JD. Epiphora during the first year of life[J]. Eye (Lond), 1991,5:596-600. [2] Mohney BG, Sathiamoorthi S, Frank RD. Spontaneous resolution rates in congenital nasolacrimal duct obstruction managed with massage or topical antibiotics compared to observation alone[J]. Br J Ophthalmol,2022,106:1196-1199. [3] Ali MJ, Kamal S, Gupta A, et al. Simple vs complex congenital nasolacrimal duct obstructions: etiology, management and outcomes[J]. Int Forum Allergy Rhinol,2015,5:174-177. [4] Farrokhi S, Schüttauf F, Spitzer MS, et al. Congenital nasolacrimal obstruction: a real-life study from the first symptoms to the results of surgical treatment[J]. Ophthalmologe,2021,118:1031-1037. [5] Sun H, Ding J, Li D, et al. Comparison of Hasner valvulotomy outcomes in pediatric and adult patients: does age matter?[J]. Chin Med J (Engl),2020,133:2422-2428. [6] Lin AE, Chang YC, Lin MY, et al. Comparison of treatment for congenital nasolacrimal duct obstruction: a systemic review and Meta-analysis[J]. Can J Ophthalmol,2016,51:34-40. [7] Sathiamoorthi S, Frank RD, Mohney BG. Spontaneous resolution and timing of intervention in congenital nasolacrimal duct obstruction[J]. JAMA Ophthalmol,2018,136:1281-1286. [8] Asano M, Takeuchi M, Ohno T, et al. Lacrimal sac massage for congenital nasolacrimal duct obstruction: a multicentre randomised controlled trial[J]. Br J Ophthalmol,2024: bjo-2023-324595. doi:10.1136/bjo-2023-324595. Online ahead of print. [9] 中华医学会眼科学分会眼整形眼眶病学组. 中国先天性鼻泪管阻塞诊疗专家共识[J]. 中华眼科杂志,2021,57:814-818. [10] 中国妇幼保健协会儿童眼保健专业委员会. 关于婴幼儿泪道相关疾病诊断及治疗的专家共识[J]. 中国斜视与小儿眼科眼科杂志,2021,29:1-4. [11] Pediatric Eye Disease Investigator Group, Repka MX, Chandler DL, et al. Primary treatment of nasolacrimal duct obstruction with probing in children less than four years old[J]. Ophthalmology,2008,115:577-584. [12] Hung CH, Chen YC, Lin SL, et al. Nasolacrimal duct probing under topical anesthesia for congenital nasolacri-mal duct obstruction in Taiwan[J]. Pediatr Neonatol,2015,56:402-407. [13] Świerczyńska M, Tobiczyk E, Rodak P, et al. Success rate of probing for congenital nasolacrimal duct obstruction at various ages[J]. BMC Ophthalmol,2020,20:403. doi:10.1186/s12886-020-01658-9. [14] Muthumalai M, Alam MS, Shrirao N, et al. A case-control study to determine the microbiological spectrum and antibiotic sensitivity patterns in congenital nasolacrimal duct obstruction[J]. J Curr Ophthalmol,2022,34:251-256. [15] Kim D, Lew H. Comparison of outcomes of silicone tube intubation with or without dacryoendoscopy for the treatment of congenital nasolacrimal duct obstruction[J]. J Clin Med,2023,12:7370. doi:10.3390/jcm12237370. |